Analysis of baseline variables for their impact on hematologic response
Factors . | No. subjects . | No. subjects with hematologic response . | Univariate P . | Multivariate P(n = 56) . |
---|---|---|---|---|
Sex | ||||
Male | 38 | 28 | .179 | NA |
Female | 25 | 22 | ||
Age* | ||||
Younger than 60 y | 38 | 33 | .078 | NA |
Older than 60 y | 25 | 17 | ||
Disease duration | ||||
Fewer than 12 mo | 16 | 14 | .426 | NA |
Longer than 12 mo | 46 | 36 | ||
Prior therapy | ||||
None, HU, IFN | 35 | 30 | .170 | NA |
Others | 28 | 20 | ||
Prior 6- Thioguanine | ||||
Yes | 58 | 46 | .971 | NA |
No | 5 | 4 | ||
Phase* | ||||
Chronic | 20 | 20 | .005 | NS |
Accelerated + blastic | 43 | 30 | ||
Clonal evolution*† | ||||
Yes | 25 | 16 | .016 | .010 |
No | 34 | 31 | ||
Splenomegaly | ||||
Yes | 43 | 35 | .772 | NA |
No | 13 | 10 | ||
Hemoglobin level* | ||||
At least 100 g/L | 24 | 15 | .016 | NS |
Less than 100 g/L | 38 | 34 | ||
White blood cell count | ||||
At least 10 × 109/L | 19 | 16 | .543 | NA |
Fewer than 10 × 109/L | 44 | 34 | ||
Platelet count* | ||||
No more than 100 × 109/L | 16 | 9 | .095 | NS |
More than 100 × 109/L but less than 450 × 109/L | 28 | 24 | ||
More than 450 | 17 | 14 | ||
Blasts in PB*‡ | ||||
5% or less | 41 | 38 | <.001 | .001 |
Greater than 5% | 20 | 10 | ||
Basophils in PB | ||||
7% or less | 42 | 32 | .540 | NA |
Greater than 7% | 18 | 15 | ||
Blasts in BM | ||||
5% or less | 29 | 29 | .942 | NA |
Greater than 5% | 25 | 15 | ||
Mutation | ||||
Yes | 14 | 9 | .123 | NA |
No | 49 | 41 |
Factors . | No. subjects . | No. subjects with hematologic response . | Univariate P . | Multivariate P(n = 56) . |
---|---|---|---|---|
Sex | ||||
Male | 38 | 28 | .179 | NA |
Female | 25 | 22 | ||
Age* | ||||
Younger than 60 y | 38 | 33 | .078 | NA |
Older than 60 y | 25 | 17 | ||
Disease duration | ||||
Fewer than 12 mo | 16 | 14 | .426 | NA |
Longer than 12 mo | 46 | 36 | ||
Prior therapy | ||||
None, HU, IFN | 35 | 30 | .170 | NA |
Others | 28 | 20 | ||
Prior 6- Thioguanine | ||||
Yes | 58 | 46 | .971 | NA |
No | 5 | 4 | ||
Phase* | ||||
Chronic | 20 | 20 | .005 | NS |
Accelerated + blastic | 43 | 30 | ||
Clonal evolution*† | ||||
Yes | 25 | 16 | .016 | .010 |
No | 34 | 31 | ||
Splenomegaly | ||||
Yes | 43 | 35 | .772 | NA |
No | 13 | 10 | ||
Hemoglobin level* | ||||
At least 100 g/L | 24 | 15 | .016 | NS |
Less than 100 g/L | 38 | 34 | ||
White blood cell count | ||||
At least 10 × 109/L | 19 | 16 | .543 | NA |
Fewer than 10 × 109/L | 44 | 34 | ||
Platelet count* | ||||
No more than 100 × 109/L | 16 | 9 | .095 | NS |
More than 100 × 109/L but less than 450 × 109/L | 28 | 24 | ||
More than 450 | 17 | 14 | ||
Blasts in PB*‡ | ||||
5% or less | 41 | 38 | <.001 | .001 |
Greater than 5% | 20 | 10 | ||
Basophils in PB | ||||
7% or less | 42 | 32 | .540 | NA |
Greater than 7% | 18 | 15 | ||
Blasts in BM | ||||
5% or less | 29 | 29 | .942 | NA |
Greater than 5% | 25 | 15 | ||
Mutation | ||||
Yes | 14 | 9 | .123 | NA |
No | 49 | 41 |